Literature DB >> 2839382

Oil or aqueous contrast media for hysterosalpingography: a prospective, randomized, clinical study.

A D de Boer1, H M Vemer, W N Willemsen, F B Sanders.   

Abstract

In this prospective randomized clinical study the pregnancy rate and the quality of the images obtained by hysterosalpingography (HSG) in 175 women with fertility problems have been compared using an oil-soluble contrast medium and an aqueous contrast medium. After the HSG there was a follow-up period of 6 months. No statistically significant difference in pregnancy rate was found. With both contrast media good images were obtained. The oil-soluble contrast medium gave a more sharply outlined uterine cavity, the aqueous contrast medium showed more tubal details. Furthermore, the control picture with the aqueous contrast medium can be prepared after ten minutes. We conclude that the use of an aqueous contrast medium for routine HSG is preferable.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839382     DOI: 10.1016/0028-2243(88)90060-3

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  3 in total

Review 1.  Tubal flushing for subfertility.

Authors:  Lamiya Mohiyiddeen; Anne Hardiman; Cheryl Fitzgerald; Edward Hughes; Ben Willem J Mol; Neil Johnson; Andrew Watson
Journal:  Cochrane Database Syst Rev       Date:  2015-05-01

2.  Treatment effect of oil-based contrast is related to experienced pain at HSG: a post-hoc analysis of the randomised H2Oil study.

Authors:  N van Welie; K Dreyer; J van Rijswijk; H R Verhoeve; M Goddijn; A W Nap; J M J Smeenk; M A F Traas; H G M Rijnsaardt-Lukassen; A J C M van Dongen; P Bourdrez; J P de Bruin; A V Sluijmer; A P Gijsen; P M van de Ven; C B Lambalk; V Mijatovic; B W J Mol
Journal:  Hum Reprod       Date:  2019-12-01       Impact factor: 6.918

3.  Effects of oil-soluble versus water-soluble contrast media at hysterosalpingography on pregnancy outcomes in women with a low risk of tubal disease: study protocol for a randomised controlled trial.

Authors:  Guiling Liang; Qian Zhu; Xiaoqing He; Xiaofeng Wang; Ling Jiang; Chenfeng Zhu; Li Xie; Zhaoxia Qian; Jian Zhang
Journal:  BMJ Open       Date:  2020-10-27       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.